Creating An Account For The Pharmaceutical Rebate Revenue Generated By The Purchase Of Medications For People Living With Hiv Who Are Enrolled In The Early Intervention Program.

Share:

Summary

User Reviews

AI Summary

This bill aims to establish a dedicated account to track pharmaceutical rebate revenue from HIV medication purchases for individuals in the early intervention program. The account will help ensure transparency and proper allocation of funds related to HIV treatment. This measure seeks to improve financial management and support for people living with HIV by effectively monitoring and utilizing rebate revenue for their care within the early intervention program.

Bill Activity

2023-01-18: First reading, referred to Appropriations.
2023-01-30: Public hearing in the House Committee on Appropriations at 4:00 PM.
2023-02-02: Executive action taken in the House Committee on Appropriations at 4:00 PM.
2023-02-02: APP - Majority; 1st substitute bill be substituted, do pass.
2023-02-07: Referred to Rules 2 Review.
2023-02-14: Rules Committee relieved of further consideration. Placed on second reading.
2023-03-13: Referred to Rules 2 Consideration.
2024-01-08: By resolution, reintroduced and retained in present status.
2024-01-08: House Rules "X" file.

Overall Bill Rating

0.0

Constitutionality

0.0

Fiscal Responsibility

0.0

Individual Liberties

0.0

Effectiveness & Feasibility

0.0

Societal Impact

0.0

Sponsors (1)

Beth Doglio (D)

Cosponsors (4)

Text Versions (2)

Introduced Comm Sub

Roll Calls (1):

Bill Discussion Board

Contributions (0)

Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.

Email Required Incorrect Email Format

Add Town Name

Description Required Description Required